Raphael Pollock, MD, oncologist and director of Ohio State University's Comprehensive Cancer Center at James Cancer Hospital, Columbus, has been battling the same disease faced by his patients. 

Scientists from Ohio State University Comprehensive Cancer Center in Columbus are leading a clinical study to better understand how certain types of cancer overpower treatment by analyzing biological samples collected from cancer patients within hours after their death. 

Eli Lilly plans to broaden patient access to clinical trials while expanding representation of minority group members by partnering with Care Access, a decentralized research organization. 

City of Hope plans to open the 190,000-square-foot Lennar Foundation Cancer Center in Irvine, Calif., next summer, local news station Spectrum News 1 reported Sept. 27. 

A drop in face-to-face patient interaction was the top factor contributing to oncologists' burnout during the pandemic prior to vaccine availability, according to recent survey findings. 

New York City-based Memorial Sloan Kettering Cancer Center has created a new center dedicated to better serving the specific needs of young cancer patients.

Phoenix Children's has selected Mario Otto, MD, PhD, to serve as director of its center for cancer and blood disorders, as well as division chief of hematology/oncology. 

Schenectady, N.Y.-based Ellis Medicine, a 438-bed community and teaching healthcare system, and Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center opened a new medical oncology center Sept. 21. 

These six oncologists joined new practices or received new appointments over the last few months. 

Enhertu, a drug made by AstraZeneca and Daiichi Sankyo, significantly lowered the risk of death or tumor progression among patients with HER2-positive breast cancer, The Wall Street Journal reports. 

The US Oncology Network selected Jason Hammonds as its new president Sept. 20 

President Joe Biden's administration appointed seven clinicians and researchers to the National Cancer Advisory Board Sept. 15. 

Mishawaka, Ind.-based Franciscan Health plans to build a 68,000-square-foot cancer center in Lafayette.

Count Me In, a research initiative that allows cancer patients to share data directly with researchers, launched the Colorectal Cancer Project Sept. 14. 

Among 38 patients with B-cell blood cancers, 21 (55 percent) produced antibodies after receiving a booster dose of an mRNA COVID-19 vaccine despite not producing detectable antibodies after the first two doses, according to a recent study led by the Leukemia & Lymphoma Society. 

Scripps Mercy Hospital San Diego, part of Scripps MD Anderson Cancer Center, opened the $59 million Prebys Cancer Center Sept. 13. 

These three oncologists joined new practices or received new appointments recently.

Recent oncology studies have focused on the severity of COVID-19 illness among pediatric cancer patients, outcomes among cancer patients diagnosed after the pandemic lockdown and more. 

Patients in France who were newly diagnosed with metastatic colorectal cancer after the country's first COVID-19 lockdown in spring 2020 had a higher tumor burden compared to those who were diagnosed before the lockdown, according to research published Sept. 8 in JAMA Network Open.

New Haven, Conn.-based Yale Cancer Center has named Edward Kaftan, PhD, to serve as the associate cancer center director for research affairs, effective Jan. 1, 2022.